Yifan Xinfu Pharmaceutical Co Ltd (002019) — Free Cash Flow Generation Index
Yifan Xinfu Pharmaceutical Co Ltd (002019) has a Free Cash Flow Generation Index of -3.60x as of September 2025. Free cash flow of CN¥-144.50 Million represents -4% of operating cash flow (CN¥40.18 Million). Read 002019 total liabilities for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Yifan Xinfu Pharmaceutical Co Ltd Free Cash Flow Generation Index (2003–2025)
Historical FCF Generation Index trend for Yifan Xinfu Pharmaceutical Co Ltd across 21 annual periods. Explore Yifan Xinfu Pharmaceutical Co Ltd (002019) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Yifan Xinfu Pharmaceutical Co Ltd (2003–2025)
Year-by-year Free Cash Flow Generation Index for Yifan Xinfu Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see 002019 stock market capitalisation.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.22x | CN¥-100.87 Million | CN¥458.37 Million | CN¥559.23 Million | ▼ -1221.3% |
| 2024 | 0.02x | CN¥12.57 Million | CN¥640.73 Million | CN¥628.16 Million | ▲ +104.4% |
| 2023 | -0.45x | CN¥-155.50 Million | CN¥348.58 Million | CN¥504.09 Million | ▼ -199.9% |
| 2022 | -0.15x | CN¥-70.21 Million | CN¥472.07 Million | CN¥542.27 Million | ▲ +83.4% |
| 2021 | -0.90x | CN¥-270.51 Million | CN¥301.23 Million | CN¥571.74 Million | ▼ -353.4% |
| 2020 | 0.35x | CN¥392.80 Million | CN¥1.11 Billion | CN¥715.71 Million | ▲ +366.7% |
| 2019 | 0.08x | CN¥71.17 Million | CN¥937.24 Million | CN¥866.07 Million | ▼ -79.9% |
| 2018 | 0.38x | CN¥441.69 Million | CN¥1.17 Billion | CN¥729.21 Million | ▼ -33.9% |
| 2017 | 0.57x | CN¥646.87 Million | CN¥1.13 Billion | CN¥485.86 Million | ▼ -14.0% |
| 2016 | 0.66x | CN¥568.34 Million | CN¥855.85 Million | CN¥287.50 Million | ▲ +44.4% |
| 2015 | 0.46x | CN¥184.81 Million | CN¥401.96 Million | CN¥217.15 Million | ▲ +27.9% |
| 2014 | 0.36x | CN¥50.23 Million | CN¥139.74 Million | CN¥89.51 Million | ▼ -56.1% |
| 2013 | 0.82x | CN¥28.10 Million | CN¥34.32 Million | CN¥73.95 Million | ▲ +164.8% |
| 2012 | -1.26x | CN¥-37.76 Million | CN¥29.88 Million | CN¥67.64 Million | ▲ +20.1% |
| 2009 | -1.58x | CN¥-92.66 Million | CN¥58.61 Million | CN¥151.27 Million | ▼ -236.4% |
| 2008 | -0.47x | CN¥-39.15 Million | CN¥83.31 Million | CN¥122.46 Million | ▼ -252.5% |
| 2007 | 0.31x | CN¥76.64 Million | CN¥248.71 Million | CN¥172.06 Million | ▲ +140.2% |
| 2006 | -0.77x | CN¥-25.01 Million | CN¥32.62 Million | CN¥57.62 Million | ▲ +46.4% |
| 2005 | -1.43x | CN¥-34.51 Million | CN¥24.12 Million | CN¥58.63 Million | ▼ -31.5% |
| 2004 | -1.09x | CN¥-36.55 Million | CN¥33.59 Million | CN¥70.14 Million | ▲ +65.4% |
| 2003 | -3.14x | CN¥-39.78 Million | CN¥12.65 Million | CN¥52.44 Million | — |